Torsten Haferlach

61.0k total citations · 2 hit papers
774 papers, 23.4k citations indexed

About

Torsten Haferlach is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Torsten Haferlach has authored 774 papers receiving a total of 23.4k indexed citations (citations by other indexed papers that have themselves been cited), including 574 papers in Hematology, 296 papers in Genetics and 249 papers in Molecular Biology. Recurrent topics in Torsten Haferlach's work include Acute Myeloid Leukemia Research (499 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (160 papers) and Chronic Myeloid Leukemia Treatments (148 papers). Torsten Haferlach is often cited by papers focused on Acute Myeloid Leukemia Research (499 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (160 papers) and Chronic Myeloid Leukemia Treatments (148 papers). Torsten Haferlach collaborates with scholars based in Germany, United States and Italy. Torsten Haferlach's co-authors include Susanne Schnittger, Wolfgang Kern, Claudia Schoch, Claudia Haferlach, Wolfgang Hiddemann, Alexander Kohlmann, Ulrike Bacher, Frank Dicker, Tamara Alpermann and Martin Dugas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Torsten Haferlach

713 papers receiving 23.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

2002 746 citations Susanne Schnittger, Wolfgang Kern et al. Blood profile →
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

2012 457 citations Torsten Haferlach et al. profile →

Peers

Countries citing papers authored by Torsten Haferlach

Since Specialization

Citations

This map shows the geographic impact of Torsten Haferlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Haferlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Haferlach more than expected).

Fields of papers citing papers by Torsten Haferlach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Haferlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Haferlach. The network helps show where Torsten Haferlach may publish in the future.

Co-authorship network of co-authors of Torsten Haferlach

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Haferlach. A scholar is included among the top collaborators of Torsten Haferlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Haferlach. Torsten Haferlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia 2025 ·npj Precision Oncology ·Jan‐Niklas Eckardt, (unknown), (unknown), Susann Winter, (unknown), (unknown), (unknown), (unknown), (unknown), Katja Sockel, (unknown), Christoph Röllig, Frank Kroschinsky, (unknown), Christian Pohlkamp, Torsten Haferlach, Martin Bornhäuser, Karsten Wendt, Jan Moritz Middeke	0
2	Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations 2025 ·Leukemia ·Maki Sakuma, (unknown), (unknown), (unknown), Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, David B. Beck, Wencke Walter	0
3	Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification 2024 ·Medizinische Genetik ·Claudia Haferlach, German Ott, (unknown), (unknown), Torsten Haferlach, Reiner Siebert	1
4	Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine 2024 ·Therapeutic Advances in Hematology ·Amer M. Zeidan, Jan Philipp Bewersdorf, (unknown), Rory M. Shallis, Ethan Thompson, Daniel L. Menezes, (unknown), Isaac W. Boss, Stephanie Halene, Torsten Haferlach, Brian A. Fox	8
5	Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes 2024 ·Genome Medicine ·(unknown), Sandra Huber, (unknown), Franziska R. Traube, Marc Seifert, Christopher C. Oakes, (unknown), (unknown), Ines F. Scheller, Nils Wagner, Vicente A. Yépez, Piers Blombery, Torsten Haferlach, Matthias Heinig, Leonhard Wachutka, Stephan Hütter, Julien Gagneur	1
6	Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS 2023 ·Blood Advances ·Anna Stengel, Torsten Haferlach, Constance Baer, Stephan Hütter, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach	16
7	A Bioinformatics View on Acute Myeloid Leukemia Surface Molecules by Combined Bayesian and ABC Analysis 2022 ·Bioengineering ·Michael C. Thrun, Elisabeth Mack, Andreas Neubauer, Torsten Haferlach, (unknown), Alfred Ultsch, Cornelia Brendel	4
8	Whole Genome Sequencing Identifies Non-KIT Mutations and Cytogenetic Aberrations in Systemic Mastocytosis but Has Limited Sensitivity for Detection of KIT D816V 2021 ·Blood ·Gregor Hoermann, Manja Meggendorfer, Constance Baer, Heiko Müller, Wencke Walter, Stephan Hütter, Christian Pohlkamp, Niroshan Nadarajah, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	0
9	Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults 2021 ·Blood ·Claudia Haferlach, Wencke Walter, Manja Meggendorfer, Anna Stengel, Constance Baer, Stephan Hütter, Niroshan Nadarajah, Heiko Müller, Wolfgang Kern, Torsten Haferlach	2
10	Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML 2021 ·Cancers ·Anna Wojtuszkiewicz, Inge van der Werf, Stephan Hütter, Wencke Walter, Constance Baer, Wolfgang Kern, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Claudia Haferlach, Jacqueline Cloos, Torsten Haferlach	4
11	Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia 2021 ·Cell stem cell ·Timothy M. Chlon, (unknown), Courtney E. Hershberger, (unknown), Kathleen Hueneman, Ashley Kuenzi Davis, Kwangmin Choi, Yi Zheng, Carmelo Gurnari, Torsten Haferlach, Richard A. Padgett, Jaroslaw P. Maciejewski, Daniel T. Starczynowski	57
12	Characterization of the Blood and Bone Marrow Microbiome of MDS Patients and Associations with Clinical Features 2020 ·Blood ·(unknown), (unknown), Yimin Huang, Janet Wang, Jesús María Hernández-Sánchez, Jaroslaw P. Maciejewski, Mehmet Koyutürk, Stephan Hütter, Torsten Haferlach, Thomas LaFramboise	1
13	Complex landscape of alternative splicing in myeloid neoplasms 2020 ·Leukemia ·Courtney E. Hershberger, (unknown), Vera Ademà, Cassandra M Kerr, Wencke Walter, Stephan Hütter, Manja Meggendorfer, Constance Baer, Wolfgang Kern, Niroshan Nadarajah, Sven Twardziok, Mikkael A. Sekeres, Claudia Haferlach, Torsten Haferlach, Jaroslaw P. Maciejewski, Richard A. Padgett	37
14	Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes 2019 ·American Journal of Hematology ·Vikas Madan, Jia Li, Siqin Zhou, (unknown), Lin Han, Manja Meggendorfer, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Torsten Haferlach, Henry Yang, H. Phillip Koeffler	13
15	Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant 2017 ·Blood ·Alexander Höllein, Anna Stengel, Manja Meggendorfer, Annette Fasan, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	3
16	Multiparameter Flow Cytometry Provides Independent Prognostic Information in Patients with Suspected Myelodysplastic Syndromes: A Study on 804 Patients 2016 ·Cytometry Part B Clinical Cytometry ·Wolfgang Kern, Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Susanne Schnittger, Torsten Haferlach	0
17	Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients 2015 ·Cytometry Part B Clinical Cytometry ·Wolfgang Kern, Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Susanne Schnittger, Torsten Haferlach	15
18	Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 2010 ·Blood ·Brunangelo Falini, Maria Paola Martelli, Niccolò Bolli, Paolo Sportoletti, Arcangelo Liso, Enrico Tiacci, Torsten Haferlach	171
19	Interactive diagnostics in the indication to allogeneic SCT in AML 2009 ·Bone Marrow Transplantation ·Ulrike Bacher, Claudia Haferlach, Susanne Schnittger, Wolfgang Kern, Nicolaus Kroeger, A R Zander, Torsten Haferlach	12
20	Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group 2008 ·Journal of Clinical Oncology ·Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach, Torsten Haferlach, Susanne Schnittger, Carsten Müller‐Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Peter Staib, Andreas Grüneisen, Wolfgang Kern, Albrecht Reichle, Georg Maschmeyer, Carlo Aul, Eva Lengfelder, Maria‐Cristina Sauerland, Achim Heinecke, Bernhard Wörmann, Wolfgang Hiddemann	232

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact